Responding to COVID-19 disruptions to blood transfusion services: A data analytics and visualization platform for blood product inventory management during COVID-19

在COVID-19大流行的情况下，由于献血者的可用性受到影响，人们对血液制品短缺的担忧日益增加;这可能会严重影响医院的运营，进而影响加拿大各地的患者安全。该项目采用数据驱动的血液制品库存管理解决方案，专为应对COVID-19疫情带来的血液制品供应和分销挑战而量身定制。该项目是新斯科舍省卫生局（NSHA）中心区输血服务（CZBTS）和达尔豪西大学研究人员之间的合作伙伴关系。该项目的成果将是一个基于人工智能（AI）的血液制品库存管理平台：（1）在交互式仪表板上可视化血液制品的近实时库存和正在进行的交易，以简化基本血液制品的分配;（二）根据血液制品的交易数据预测血液制品是否可能被丢弃，以便管理员可以主动采取行动，丢弃;（3）防止血液制品过期。该项目的影响将是有效管理血液制品，以便在COVID-19疫情导致供应中断的情况下仍能提供基本医疗服务。

In the context of the COVID-19 pandemic, there is an increased concern around shortages of blood products due to impacts on the availability of blood donors; this could seriously affect the operations of hospitals and, in turn, patient safety across Canada. This project takes a data-driven blood product inventory management solution, specifically tailored to respond to blood product supply and distribution challenges due to the COVID-19 pandemic. This project is a partnership between Nova Scotia Health Authority (NSHA) Central Zone Blood Transfusion Services (CZBTS) and Dalhousie University researchers. The project outcome will be an Artificial Intelligence (AI) based blood product inventory management platform to: (1) visualize on an interactive dashboard the near real-time inventory and on-going transactions of blood products to streamline the distribution of essential blood products; (2) predict whether a blood product is likely to be discarded based on its transactional data so that administrators can proactively act to avoid its discard; and (3) prevent the expiration of blood products. The project's impact will be the effective management of blood products so that essential healthcare services can be delivered despite supply disruptions due to COVID-19 pandemic.